Nuclear Diagnostics
Medical Indications for PET/CT
PET/CT method has no competitors in oncology that could equally detect: diagnosis, cancer staging, treatment response evaluation, cancer recurrence, disease dynamics and control, surgical planning, radiation therapy planning. New generation PET/CT incorporates the majority of oncological radioisotope imaging for a wide range of malignant diseases, using radiotracers such as ¹⁸F-FDG and ⁶⁸Ga-PSMA (Unique in the Baltics):
Breast
cancer
Melanoma
Gastric
cancer
Colorectal
cancer
Lymphomas
Lung
cancer
Kidney
cancer
Uterine, Cervical, Ovarian cancer
Testicular
cancer
Bladder
cancer
Prostate
cancer
UNKNOWN
LOCALIZATION
Professional testimonials
Doctor's Opinions on PET/CT
![]()
It is important to emphasize that PET/CT is a multimodality whole-body scan. Other conventional high-resolution modalities as CT alone and MR excel at providing structural details however they provide little insight into tumor physiology. PET is used to provide insight into a tumor's biologic functions and its surrounding microenvironment. Thus, PET may detect biochemical changes in an organ or tissue that can identify the onset of a disease process before anatomical changes related to the disease can be seen with other imaging processes, such as computed tomography (CT scan) or magnetic resonance imaging (MRI).
Marika Kalnina
![]()
IT IS TOO LATE WHEN CT DEMONSTRATES THE LESION!
There are oncological diseases as e.g. ovarian cancer when we see an elevated CA-125 level in dynamic modelling at the stage where no changes are yet demonstrated by ultrasound and computer tomography (CT). It is one of clinical situations when PET/CT scan, due to its sensitivity and specificity, will disclose disease activity earlier. The imaging tool recognizes pathological formations from up to 1 cm in size and allows for identification of cancer-related formations.
Aija Gerina-Berzina
![]()
What is the size of metastases that can be detected by PET/CT?
According to literature – from up to 9 millimetres. But in practice we can see smaller ones. A lymph node of 4 millimetres in size, but it glows! We measure intensity of radiation accumulation, which is an objective parameter, and it shows that the node intensively consumes glucose. It is clear that the node is malignant.
Lilita Roznere
![]()
Specifically, PET/CT studies evaluate the metabolism of a particular organ or tissue, so that information about the physiology (functionality) and anatomy (structure) of the organ or tissue is evaluated, as well as its biochemical properties. Integrating PET with a CT maximizes their separate strengths and provides anatomic localization of physiologic processes with detailed visualization of a tumor's structure. The availability of multi-modality (hybrid) imaging with PET/CT improves our ability to characterize lesions and to affect treatment decisions and patient management.
Marika Kalnina
![]()
We are pleased to be the first medicine centre in Latvia providing a wide range of cancer diagnostics with high quality PET/CT technology and especially proud to be among the rare European PET/CT centres offering progressive prostate cancer diagnostics with innovative 68Ga-PSMA. We are also proud to be the only PET/CT facility in the Baltic countries having on-site cyclotron for production of positron emitters and supplying them straight to the examination site. Rīga Stradiņš university Nuclear Medicine Clinic has formed a stable team of highly qualified professionals with international educational and training background in the Nuclear Medicine. I am sure that besides the high-quality examination the patient will also be pleased due to the very competitive price, knowledge of our professional staff and welcoming attitude.
Vitālijs Skrīvelis
